Rangwala Reshma
EVP &Chief Medical Officer
1 company
Insider Signal Score
67
StrongTrades Analyzed
8
12M Win Rate
66.7%
Avg 3M Return
+22.3%
Avg 12M Return
+26.8%
Rangwala Reshma is an EVP &Chief Medical Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $108K based on current market prices.
Holdings by Company
KPTIApr 21, 2026
Current Shares56.3K
Value$107.8K
Net Activity-40,058
Bought: 0Sold: 40.1K
Transaction History
Showing 7 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Medical Officer | Sell | 449 | $8.94 | $4,014.06 | -0.8% | +2.3% | - | |
| Sep 15, 2025 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Medical Officer | Sell | 408 | $6.43 | $2,623.44 | -1.4% | +7.2% | - | |
| Apr 23, 2025 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Medical Officer | Sell | 419 | $6.17 | $2,585.23 | -1.4% | -38.0% | +39.6% | |
| Mar 4, 2025 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Medical Officer | Sell | 3,587 | $6.29 | $22,562.23 | -10.9% | -35.3% | +43.1% | |
| Apr 22, 2024 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Medical Officer | Sell | 6,789 | $1.17 | $7,943.13 | -1.9% | -19.4% | -64.4% | |
| Mar 1, 2024 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Medical Officer | Sell | 21,636 | $1.18 | $25,493.19 | -3.0% | -20.0% | -55.3% | |
| Apr 20, 2023 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Medical Officer | Sell | 6,770 | $4.05 | $27,415.82 | -2.1% | -57.9% | -69.2% |